4.6 Article

Cytotoxic activity of 4 '-hydroxychalcone derivatives against Jurkat cells and their effects on mammalian DNA topoisomerase I

Journal

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/14756360802399126

Keywords

4 '-hydroxychalcone; cytotoxicity; Jurkat cells; MTT; DNA topoisomerase I; inhibition

Ask authors/readers for more resources

Chalcones (1,3-diaryl-2-propen-1-ones) are alpha, beta-unsaturated ketones with cytotoxic and anticancer properties. Several reports have shown that compounds with cytotoxic properties may also interfere with DNA topoisomerase functions. Five derivatives of 4'-hydroxychalcones were examined for cytotoxicity against transformed human T (Jurkat) cells as well as plasmid supercoil relaxation experiments using mammalian DNA topoisomerase I. The compounds were 3-phenyl-1-(4'-hydroxyphenyl)-2-propen-1-one (I), 3-(p-methylphenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (II), 3-(p-methoxyphenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (III), 3-(p-chlorophenyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (IV), and 3-(2- thienyl)-1-(4'-hydroxyphenyl)-2-propen-1-one (V). The order of the cytotoxicity of the compounds was; IV > III > II > I > V. Compound IV, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest DNA topoisomerase I inhibition. Compounds I and II gave moderate interference with the DNA topoisomerase I while III & V did not interfere with the enzyme.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Andrology

Oxidative stress before and after surgery in benign prostatic hyperplasia patients

Mehlika Ercan, Hamit Hakan Alp, Huseyin Kocaturk, Nuri Bakan, Mustafa Gul

ANDROLOGIA (2019)

Article Chemistry, Organic

Synthesis, cytotoxic, and carbonic anhydrase inhibitory effects of new 2-(3-(4-methoxyphenyl)-5-(aryl)-4,5-dihydro-1H-pyrazol-1-yl)benzo[d]thiazole derivatives

Mehtap Tugrak, Halise Inci Gul, Hiroshi Sakagami, Ilhami Gulcin

JOURNAL OF HETEROCYCLIC CHEMISTRY (2020)

Article Chemistry, Medicinal

Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors

Mehtap Tugrak, Halise Inci Gul, Yeliz Demir, Ilhami Gulcin

Summary: A series of novel compounds with potential and selective inhibitory effects on human carbonic anhydrase I and II were synthesized, demonstrating promise as candidate drugs for treating glaucoma. Some compounds showed significant inhibitory effects against the target proteins, highlighting their potential for further investigation as lead compounds in alleviating glaucoma symptoms.

ARCHIV DER PHARMAZIE (2021)

Article Chemistry, Medicinal

Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone-based benzenesulfonamides

Mehtap Tugrak, Halise Inci Gul, Yeliz Demir, Serkan Levent, Ilhami Gulcin

Summary: New imidazolinone-based benzenesulfonamides were synthesized and evaluated for their potential as drug candidates by testing their activities against carbonic anhydrase (CA) and acetylcholinesterase (AChE) enzymes. Compounds with nitro group showed increased selectivity in CA inhibition compared to their hydrogen counterparts, while compounds with sulfanilamide moiety exhibited the best AChE inhibitory potency.

ARCHIV DER PHARMAZIE (2021)

Review Chemistry, Medicinal

Silver(I)-N-heterocyclic carbene complexes challenge cancer; evaluation of their anticancer properties and in silico studies

Serap Sahin-Bolukbasi, Pakize Canturk-Kilickaya, Ozan Kilickaya

Summary: The pharmaceutical industry is using computational tools more frequently to screen drug candidates, with N-heterocyclic carbenes (NHCs) being evaluated as potential candidates due to their anti-cancer and anti-inflammatory properties. Recent studies have focused on Ag(I)-NHC complexes and their anti-cancer activities, as well as the utilization of density functional theory and structure-activity relationship in drug development.

DRUG DEVELOPMENT RESEARCH (2021)

Review Biochemistry & Molecular Biology

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development

Reem Aljanabi, Lina Alsous, Dima A. Sabbah, Halise Inci Gul, Mustafa Gul, Sanaa K. Bardaweel

Summary: Monoamine oxidases (MAOs) are oxidative enzymes responsible for converting biogenic amines into aldehydes and ketones. Distorted activity of MAOs has been linked to neurological diseases, and recent studies have found unexpected roles of MAOs in tumor progression and metastasis. Chemical inhibition of MAOs may be a valuable therapeutic approach for cancer treatment.

MOLECULES (2021)

Article Chemistry, Medicinal

Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Precancerous Lung Injuries

Betul Cicek, Ahmet Hacimuftuoglu, Mehmet Kuzucu, Ahmet Cetin, Yesim Yeni, Sidika Genc, Serkan Yildirim, Ismail Bolat, Mecit Kantarci, Mustafa Gul, Serhat Hayme, Dimitris Matthaios, Dimitra P. P. Vageli, Sotirios G. G. Doukas, Aristidis Tsatsakis, Ali Taghizadehghalehjoughi

Summary: According to population-based studies, lung cancer is the most common cause of cancer-related deaths worldwide in males, and its incidence among females is also increasing alarmingly. Sorafenib (SOR), a multitargeted protein kinase inhibitor used for the treatment of hepatocellular carcinoma and renal cell carcinoma, has been the subject of interest in preclinical and clinical trials for lung cancer. This study aimed to investigate the effects of SOR in diethylnitrosamine (DEN)-induced lung carcinogenesis and explore its mechanisms of action. The results showed that SOR reduced the levels of SOX-2, TNF-alpha, and IL-1 beta, and alleviated the histopathological damage caused by DEN-induced lung carcinogenesis. Immunohistochemical and immunofluorescence analysis also revealed that SOR treatment decreased the expression of COX-2 and JNK in DEN-intoxicated rats. These findings suggest that SOR inhibits lung precancerous lesions induced by DEN through reducing inflammation and SOX-2 levels.

PHARMACEUTICALS (2023)

Article Medicine, Research & Experimental

Effects of Melatonin Administration on Vasomotor Activity and Histological Structure of Isolated Thoracic Aorta in Rats Treated with Thyroxine

Hilal Ustundag, Esra Senturk, Serkan Yildirim, Fikret celebi, Mustafa Gul

Summary: The objective of this study was to investigate the effects of in vivo melatonin administration on thoracic aorta in thyroxine-treated rats and its role in the aortic response to contractile agents. The results demonstrated that melatonin partially attenuated the reduction in contraction responses caused by thyroxine treatment. Immunohistological findings indicated that melatonin inhibited vessel wall thickening by suppressing collagen formation.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES (2023)

Review Chemistry, Medicinal

Current Pharmaceutical Research on the Significant Pharmacophore Mannich bases in Drug Design

Cem Yamali, Mustafa Gul, Halise Inci Gul

Summary: A multitude of Mannich bases have been synthesized and evaluated for their potential therapeutic applications, showing enhanced biological activity and altered physicochemical properties of drug candidates.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Evaluation of the Anticancer and Biological Activities of Istaroxime via Ex Vivo Analyses, Molecular Docking and Conceptual Density Functional Theory Computations

Ege Gok, Naz Unal, Burcin Gungor, Gulderen Karakus, Savas Kaya, Pakize Canturk, Konstantin P. Katin

Summary: Cancer is a disease caused by abnormal or uncontrolled growth of cells due to DNA damage. This study evaluated the anticancer effects of Istaroxime, a compound that inhibits Sarco-endoplasmic reticulum Ca2+ATPase (SERCA2a). The results showed that Istaroxime exhibited an antiproliferative effect on cancer cell lines and inhibited Topoisomerase I, indicating its potential as a Topoisomerase I inhibitor. Molecular docking analysis and chemical reactivity computations further supported these findings.

MOLECULES (2023)

Article Chemistry, Multidisciplinary

Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors

Mehtap Tugrak, Halise Inci Gul, Hiroshi Sakagami, Ruya Kaya, Ilhami Gulcin

Summary: Cancer is characterized by uncontrolled cell growth, and developing new drug candidate compounds is necessary due to limitations and side effects of existing drugs. In this study, new pyrazole-sulphonamide hybrid compounds were designed and synthesized, with compounds 4i and 4g showing the highest cytotoxicity values. These compounds have the potential to be lead compounds for further research.

TURKISH JOURNAL OF CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Synthesis and pharmacological effects of novel benzenesulfonamides carrying benzamide moiety as carbonic anhydrase and acetylcholinesterase inhibitors

Mehtap Tugrak, Halise Inci Gul, Baris Anil, Ilhami Gulcin

TURKISH JOURNAL OF CHEMISTRY (2020)

Meeting Abstract Physiology

Determination of Glutathione Reductase Enzyme Activity in Melatonin Administered Rats's Heart Tissue

Betul Cicek, Esra Senturk, Mustafa Gul, Fikret Celebi, Hilal Ustundag, Murat Senturk

ACTA PHYSIOLOGICA (2019)

No Data Available